Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -4.781% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CC(C)CCNC(=O)CN(CCN1CCOCC1)C(=O)Cn1nnc(-c2ccc(F)cc2)n1
b Cc1ccccc1CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)c1ccco1
c CCOC(=O)c1sc2nc(C(C)C)c3c(c2c1N)CCC3
Answer: c. CCOC(=O)c1sc2nc(C(C)C)c3c(c2c1N)CCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1sc2nc(C(C)C)c3c(c2c1N)CCC3
CCOC(=O)c1sc2nc(C(C)C)c3c(c2c1N)CCC3
ethyl 3-amino-8-propan-2-yl-5-thia-7-azatricyclo[7.3.0.02,6]dodeca-1(9),2(6),3,7-tetraene-4-carboxylate